Bottom line
How much do BBH and GNOM overlap?
23% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 38.2% of BBH's assets and 29.1% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.
GNOM holds far more positions (51 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and GNOM have in common
| Holding | % of BBH | % of GNOM | Overlap |
|---|---|---|---|
| Gilead Sciences Inc | 12.79% | 1.95% | 1.95% |
| Vertex Pharmaceuticals Inc | 9.10% | 3.95% | 3.95% |
| Natera Inc | 4.92% | 4.15% | 4.15% |
| Moderna Inc | 3.36% | 3.28% | 3.28% |
| Illumina Inc | 3.17% | 4.82% | 3.17% |
| BioNTech SE | 1.94% | 3.41% | 1.94% |
| Bio-Techne Corp | 1.54% | 3.41% | 1.54% |
| BioMarin Pharmaceutical Inc | 1.34% | 4.09% | 1.34% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Amgen Inc — 15.25%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
- United Therapeutics Corp — 2.83%
- BeOne Medicines Ltd — 2.81%
- Insmed Inc — 2.67%
- Incyte Corp — 2.49%
- Neurocrine Biosciences Inc — 2.08%
- Icon Plc — 1.90%
- Charles River Laboratories International Inc — 1.50%
- Qiagen Nv — 1.06%
Only in GNOM
- Guardant Health, Inc. — 5.59%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- CRISPR Therapeutics AG — 3.85%
- Veracyte Inc — 3.64%
- Qiagen N.V. — 3.54%
- 10X Genomics Inc — 3.23%
- Beam Therapeutics Inc — 3.09%
- Bnyrepos — 3.05%
- Eli Lilly And Company — 2.32%
- Ultragenyx Pharmaceutical Inc — 2.25%
- Caris Life Sciences, Inc. — 2.03%
- Genscript Biotech Corp — 2.00%
Asset mix
| Asset type | BBH | GNOM |
|---|---|---|
| Stocks | 100.0% | 99.9% |
| Repurchase agreements | — | 3.1% |
| Cash & short-term funds | 0.1% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | BBH | GNOM |
|---|---|---|
| US | 87.3% | 99.1% |
| NL | 6.0% | — |
| CH | 2.8% | — |
| HK | — | 2.0% |
| DE | 1.9% | — |
| IE | 1.9% | — |
| GB | — | 1.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do BBH and GNOM overlap?
What stocks do BBH and GNOM have in common?
Should I own both BBH and GNOM?
Which holds more stocks, BBH or GNOM?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.